Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.0051 | 0.9 |
mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |